• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    How Investors Are Reacting To Herbalife (HLF) Slowing Sales Growth

    Simply Wall St·10/08/2026 22:26:43
    Listen to the news
    • Herbalife recently reported organic revenue growth of 1.3% year on year and an 8.3% annual decline in earnings per share over the past three years, pointing to softer demand and margin pressure.
    • The combination of slow top line progress and shrinking earnings per share suggests Herbalife is finding it harder to convert modest sales gains into shareholder level profitability.
    • We will now look at how Herbalife's slower organic revenue growth reshapes the broader investment narrative around its long term ambitions.

    Compare Herbalife's pattern of slow top line progress and earnings pressure with a curated group of sturdier balance sheet plays using our list of solid balance sheet and fundamentals (25 results).

    Herbalife Investment Narrative Recap

    To own Herbalife, you need to believe that modest organic revenue growth can eventually translate into cleaner, more sustainable profitability. The recent 1.3% organic sales uplift alongside an 8.3% annual EPS decline over three years highlights that this is not happening yet. The key short term swing factor is execution on margin, especially product mix, pricing, and cost control.

    The biggest operational risk right now is that weak volume in China and EMEA, combined with existing gross margin pressure, keeps squeezing earnings even if sales inch higher. The latest numbers reinforce that concern rather than changing it. The news reads as incremental evidence, not a fundamental reset.

    With no fresh company announcement tied directly to this update, the most relevant reference point remains management’s broader push into personalized nutrition and subscription style offerings such as Bioniq Go, Pro2col and Life I/O products. These are designed to deepen engagement and increase repeat purchases across Herbalife’s existing customer base.

    For you as a shareholder, the key question is whether these platforms can offset sluggish core demand and regional softness. If the rollout of Pro2col, e commerce upgrades and smart device integrations leads to better distributor productivity and stickier customers, they could help narrow the current gap between modest top line progress and pressured EPS. Execution on that plan is the catalyst to watch.

    What The Current Forecasts Assume For Herbalife

    Herbalife's consensus story points to revenue of US$5.6b and earnings of US$465.5m by 2029. These figures are built on analysts' assumption of 2.6% yearly revenue growth and an earnings increase of about US$301m from current earnings of US$164.2m.

    Uncover why Herbalife's fair value indicates a 33% potential upside to its current price, which could narrow quickly.

    NYSE:HLF 1-Year Stock Price Chart
    NYSE:HLF 1-Year Stock Price Chart

    Exploring Other Perspectives

    One bullish twist on Herbalife focuses on India as a long term growth engine. The most optimistic analysts were pencilling in revenue of about US$5.7b and earnings near US$469.1m by 2029 before this update. That is far rosier than consensus, and this fresh set of numbers may nudge those views in either direction.

    Explore 4 other Herbalife fair value estimates, including one that suggests as much as 336% upside from the current price!

    Form Your Own Verdict

    Don't just follow the ticker; dig into the data and build a conviction that's truly your own.

    Looking For More Herbalife-Sized Investment Ideas?

    Once you have a view on Herbalife, it can help to set it beside a wider watchlist of companies with different balance sheets, income profiles, and return drivers. The Simply Wall St Screener is built for exactly that kind of comparison across multiple angles.

    • If you want potential mispricing opportunities, scan through our 27 high quality undervalued stocks that combine stronger fundamentals with more modest expectations baked into current prices.
    • For income focused ideas, narrow in on companies offering reliable cash returns to shareholders using the 8 dividend fortresses so you can weigh yield against payout quality and balance sheet strength.
    • When capital preservation is a priority, refine your watchlist to stocks with steadier risk profiles by filtering through the 31 resilient stocks with low risk scores tailored to highlight companies with more resilient characteristics.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.